Log In
BCIQ
Print this Print this
 

Winlevi, cortexolone 17-alpha propionate (CB-03-01)

  Manage Alerts
Collapse Summary General Information
Company Cassiopea S.p.A.
DescriptionSteroid ester androgen antagonist derived from 11-deoxycortisone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAcne
Indication DetailsTreat acne; Treat acne vulgaris; Treat skin disorders including acne, alopecia and hirsutism
Regulatory Designation
PartnerIntrepid Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/09/2012

Undisclosed

$25.0M

Undisclosed

Get a free BioCentury trial today